References
- Ramaswamy, S.; Ross, K. N.; Lander, E. S.; Golub, T. R. A Molecular Signature of Metastasis in Primary Solid Tumors. Nat. Genet. 2003, 33(1), 49–54. DOI: https://doi.org/10.1038/ng1060.
- Poole, T. J.; Coffin, J. D. Vasculogenesis and Angiogenesis: Two Distinct Morphogenetic Mechanisms Establish Embryonic Vascular Pattern. J. Exp. Zool. 1989, 251(2), 224–231. DOI: https://doi.org/10.1002/jez.1402510210.
- Zhang, H.; van Olden, C.; Sweeney, D.; Martin-Rendon, E. Blood Vessel Repair and Regeneration in the Ischaemic Heart. Open Hear. 2014, 1(1), e000016–e000016. DOI: https://doi.org/10.1136/openhrt-2013-000016.
- Liu, J.; Wang, Y.; Akamatsu, Y.; Lee, C. C.; Anne, R.; Lawton, M. T.; Yang, G. Vascular Remodeling after Ischemic Stroke: Mechanism and Therapeutic Potentials. Prog Neurobiol. 2015, 115, 138–156. DOI:https://doi.org/10.1016/j.pneurobio.2013.11.004.Vascular.
- Folkman, J.;. Role of Angiogenesis in Tumor Growth and Metastasis. Semin. Oncol. 2002, 29(6Q), 15-8. DOI: https://doi.org/10.1053/sonc.2002.37263.
- Carmeliet, P.; Jain, R. K. Angiogenesis in Cancer and Other Diseases. Nature. 2000, 407, 249–257. DOI: https://doi.org/10.1038/35025220.
- Hillen, F.; Griffioen, A. W. Tumour Vascularization: Sprouting Angiogenesis and Beyond. Cancer Metastasis Rev. 2007, 26(3–4), 489–502. DOI: https://doi.org/10.1007/s10555-007-9094-7.
- WH, D.; TF, D. Tumor Secretion of Growth Factors. Endocrinol. Metab. Clin North Am. Sep 1991, 20(3), 539–563. DOI: https://doi.org/10.1016/S0889-8529(18)30258-5.
- Kewley, R. J.; Whitelaw, M. L.; Chapman-Smith, A. The Mammalian Basic Helix-Loop-Helix/PAS Family of Transcriptional Regulators. Int. J. Biochem. Cell Biol. 2004, 36(2), 189–204. DOI: https://doi.org/10.1016/S1357-2725(03)00211-5.
- Madanecki, P.; Kapoor, N.; Bebok, Z.; Ochocka, R.; Collawn, J. F.; Bartoszewski, R. Regulation of Angiogenesis by Hypoxia: The Role of MicroRNA. Cell. Mol. Biol. Lett. 2013, 18(1), 47–57. DOI: https://doi.org/10.2478/s11658-012-0037-0.
- Jiang, B. H.; Rue, E.; Wang, G. L.; Roe, R.; Semenza, G. L. Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-Inducible Factor 1. J. Biol. Chem. 1996, 271(30), 17771–17778. DOI: https://doi.org/10.1074/JBC.271.30.17771.
- Chan, D. A.; Sutphin, P. D.; Yen, S.; Giaccia, A. J. Coordinate Regulation of the Oxygen-Dependent Degradation Domains of Hypoxia-Inducible Factor 1 α Coordinate Regulation of the Oxygen-Dependent Degradation Domains of Hypoxia-Inducible Factor 1. Mol. Cell. Biol. 2005, 25(15), 6415–6426. DOI: https://doi.org/10.1128/MCB.25.15.6415.
- Marxsen, J. H.; Stengel, P.; Doege, K.; Heikkinen, P.; Jokilehto, T.; Wagner, T.; Jelkmann, W.; Jaakkola, P.; Metzen, E. Hypoxia-Inducible Factor-1 (HIF-1) Promotes Its Degradation by Induction of HIF- α -prolyl-4-hydroxylases. Biochem. J. 2004, 767, 761–767.
- Moniz, S.; Biddlestone, J.; Rocha, S. Grow₂: The HIF System, Energy Homeostasis and the Cell Cycle. Histol. Histopathol. 2014, 29, 589–600. DOI: https://doi.org/10.14670/HH-29.10.589.
- Burslem, G. M.; Kyle, H. F.; Nelson, A.; Edwards, T. A.; Wilson, A. J. Hypoxia Inducible Factor (HIF) as a Model for Studying Inhibition of Protein–Protein Interactions. Chem. Sci. 2017, 8, 4188–4202. DOI: https://doi.org/10.1039/C7SC00388A
- Huang, X.; Ding, L.; Bennewith, K.; Tong, R.; Ang, K. K.; Le, Q.; Giaccia, A. J. Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation. . Molecular Cell NIH Public Access. Optics Letters. 2010, 35(6), 856–867. DOI: https://doi.org/10.1016/j.molcel.2009.09.006.Hypoxia.
- Senger, D. R.; Galli, S. J.; Dvorak, A. M.; Perruzzi, C. A.; Harvey, V. S.; Dvorak, H. F. Tumor Cells Secrete a Vascular Permeability Factor that Promotes Accumulation of Ascites Fluid. Science. 1983, 219(4587), 983–985. DOI: https://doi.org/10.1126/science.6823562.
- Lin, S. C.; Wang, C. C.; Wu, M. H.; Yang, S. H.; Li, Y. H.; Tsai, S. J. Hypoxia-Induced MicroRNA-20a Expression Increases ERK Phosphorylation and Angiogenic Gene Expression in Endometriotic Stromal Cells. J. Clin. Endocrinol. Metab. 2012, 97(8), 1515–1523. DOI: https://doi.org/10.1210/jc.2012-1450.
- Cascio, S.; D’Andrea, A.; Ferla, R.; Surmacz, E.; Gulotta, E.; Amodeo, V.; Bazan, V.; Gebbia, N.; Russo, A. MiR-20b Modulates VEGF Expression by Targeting HIF-1α and STAT3 in MCF-7 Breast Cancer Cells. J. Cell. Physiol. 2010, 224(1), 242–249. DOI: https://doi.org/10.1002/jcp.22126.
- Dang, K.; Myers, K. A. The Role of Hypoxia-Induced MiR-210 in Cancer Progression. Int. J. Mol. Sci. 2015, 16(3), 6353–6372. DOI: https://doi.org/10.3390/ijms16036353.
- Ghosh, G.; Subramanian, I. V.; Adhikari, N.; Zhang, X.; Joshi, H. P.; Basi, D.; Chandrashekhar, Y. S.; Hall, J. L.; Roy, S.; Zeng, Y.;, et al. Hypoxia-Induced MicroRNA-424 Expression in Human Endothelial Cells Regulates HIF-Alpha Isoforms and Promotes Angiogenesis. J. Clin. Invest. 2010, 120(11), 4141–4154. DOI: https://doi.org/10.1172/JCI42980DS1.
- Kelly, T. J.; Souza, A. L.; Clish, C. B.; Puigserver, P. A Hypoxia-Induced Positive Feedback Loop Promotes Hypoxia-Inducible Factor 1 ␣ Stability through MiR-210 Suppression Of. Mol. Cell. Biol. 2011, 31(13), 2696–2706. DOI: https://doi.org/10.1128/MCB.01242-10.
- Gee, H. E.; Ivan, C.; Calin, G. A.; Ivan, M. HypoxamiRs and Cancer: From Biology to Targeted Therapy. Antioxid. Redox Signal. 2013, 00(8), 1–19. DOI: https://doi.org/10.1089/ars.2013.5639.
- Huang, L. E.; Arany, Z.; David, M.; Bunn, H. F.; Huang, L. E.; Arany, Z.; Livingston, D. M.; Bunn, H. F. Molecular Genetics: Activation of Hypoxia-Inducible Transcription Factor Depends Primarily upon Redox-Sensitive Stabilization of Its α Subunit Activation of Hypoxia-Inducible Transcription Factor Depends Primarily upon Redox-Sensitive Stabilization of Its ␣ Subunit *. J Biol Chem. 1996. DOI: https://doi.org/10.1074/jbc.271.50.32253.
- Angiogenesis, T.; Welsh, S. J.; Bellamy, W. T.; Briehl, M. M.; Powis, G. The Redox Protein Thioredoxin-1 (Trx-1) Increases Hypoxia-Inducible Factor 1 ␣ Protein Expression : Trx-1 Overexpression Results in Increased Vascular Endothelial Growth Factor Production and Enhanced. Cancer Res.2002, 1(48), 5089–5095.
- Pepper, M. S.; Pepper, M. S. Lymphangiogenesis and Tumor Metastasis : Myth or Reality? Lymphangiogenesis and Tumor Metastasis : Myth or Reality? 1. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2001, 7(March), 462–468.
- Cross, M. J.; Claesson-Welsh, L. FGF and VEGF Function in Angiogenesis: Signalling Pathways, Biological Responses and Therapeutic Inhibition. Trends Pharmacol. Sci. 2001, 22(4), 201–207. DOI: https://doi.org/10.1016/S0165-6147(00)01676-X.
- Shreeniwas, R.; Koga, S.; Karakurum, M.; Pinsky, D.; Kaiser, E.; Brett, J.; Wolitzky, B. A.; Norton, C.; Plocinski, J.; Benjamin, W.;, et al. Hypoxia-Mediated Induction of Endothelial Cell Interleukin-1α. An Autocrine Mechanism Promoting Expression of Leukocyte Adhesion Molecules on the Vessel Surface. J. Clin. Invest. 1992, 90(6), 2333–2339. DOI: https://doi.org/10.1172/JCI116122.
- Shing, Y.; Folkman, J.; Sullivan, R.; Butterfield, C.; Murray, J.; Klagsbrun, M. Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor. Science. 1984, 223, 1296–1299. DOI: https://doi.org/10.1126/science.6199844.
- Vlodavsky, I.; Bar-Shavit, R.; Ishai-Michaeli, R.; Bashkin, P.; Fuks, Z. Extracellular Sequestration and Release of Fibroblast Growth Factor: A Regulatory Mechanism? Trends Biochem. Sci. 1991, 16(July), 268–271. DOI: https://doi.org/10.1016/0968-0004(91)90102-2.
- Kuwabara, K.; Ogawa, S.; Matsumoto, M.; Koga, S.; Clauss, M.; Pinsky, D. J.; Lyn, P.; Leavy, J.; Witte, L.; Joseph-Silverstein, J. Hypoxia-Mediated Induction of Acidic/Basic Fibroblast Growth Factor and Platelet-Derived Growth Factor in Mononuclear Phagocytes Stimulates Growth of Hypoxic Endothelial Cells. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 4606–4610. DOI: https://doi.org/10.1073/pnas.92.10.4606.
- Krock, B. L.; Skuli, N.; Simon, M. C. Hypoxia-Induced Angiogenesis: Good and Evil. Genes Cancer. 2011, 2(12), 1117–1133. DOI: https://doi.org/10.1177/1947601911423654.
- Ito, N.; Kawata, S.; Tamura, S.; Shirai, Y.; Kiso, S.; Tsushima, H.; Matsuzawa, Y. Positive Correlation of Plasma Transforming Growth Factor-?1 Levels with Tumor Vascularity in Hepatocellular Carcinoma. Cancer Lett. 1995, 89(1), 45–48. DOI: https://doi.org/10.1016/0304-3835(95)90156-6.
- Sun, D.; Kar, S.; Carr, B. I. Differentially Expressed Genes in TGF-Beta 1 Sensitive and Resistant Human Hepatoma Cells. Cancer Lett. 1995, 89(1), 73–79. DOI: https://doi.org/10.1016/0304-3835(95)90160-4.
- Ellis, L. M.;. Epidermal Growth Factor Receptor in Tumor Angiogenesis. Hematol. Oncol. Clin. North Am. 2004, 18(5), 1007–1021. DOI: https://doi.org/10.1016/j.hoc.2004.06.002.
- Taylor, S.; Folkman, J. Protamine Is an Inhibitor of Angiogenesis. Nature. 1982, 297, 307–312. DOI: https://doi.org/10.1038/297307a0.
- Pardali, E.; Dijke, P. Transforming Growth Factor-Beta Signaling and Tumor Angiogenesis. Mol. Cell. 2009, 5, 4848–4861.
- De Jong, J. S.; Van Diest, P. J.; Van Der Valk, P.; Baak, J. P. A. Expression of Growth Factors, Growth-Inhibiting Factors, and Their Receptors in Invasive Breast Cancer. II: Correlations with Proliferation and Angiogenesis. J. Pathol. 1998, 184(1), 53–57. DOI: https://doi.org/10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7.
- Nakamura, H.; Makino, Y.; Okamoto, K.; Poellinger, L.; Ohnuma, K.; Morimoto, C.; Tanaka, H. TCR Engagement Increases Hypoxia-Inducible Factor-1 Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells. J. Immunol. 2005, 174(12), 7592–7599. DOI: https://doi.org/10.4049/jimmunol.174.12.7592.
- Dang, E. V.; Barbi, J.; Yang, H. Y.; Jinasena, D.; Yu, H.; Zheng, Y.; Bordman, Z.; Fu, J.; Kim, Y.; Yen, H. R.;, et al. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1. Cell 2011, 146(5), 772–784. DOI: https://doi.org/10.1016/j.cell.2011.07.033.
- Babu, B. R.; Frey, C.; Griffith, O. W. L -arginine Binding to Nitric-Oxide Synthase. The Role of H-bonds to the Nonreactive Guanidinium Nitrogens.The Journal of Biological Chemistry. 1999, 274(36), 25218–25226. DOI: https://doi.org/10.1074/jbc.274.36.25218.
- Melillo, B. G.; Musso, T.; Sica, A.; Taylor, L. S.; Cox, G. W.; Varesio, L. A Hypoxia-Responsive Element Mediates A Novel Pathway of Activation of the Inducible Nitric Oxide Synthase Promoter. J Exp Med. 1995, 182(December).
- Strijdom, H.; Friedrich, S. O.; Hattingh, S.; Chamane, N.; Lochner, A. Hypoxia-Induced Regulation of Nitric Oxide Synthase in Cardiac Endothelial Cells and Myocytes and the Role of the PI3-K/PKB Pathway. Mol. Cell. Biochem. 2009, 321(1–2), 23–35. DOI: https://doi.org/10.1007/s11010-008-9906-2.
- Eliceiri, B. P.; Paul, R.; Schwartzberg, P. L.; Hood, J. D.; Leng, J.; Cheresh, D. A. Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability. Mol. Cell. 1999, 4(6), 915–924. DOI: https://doi.org/10.1016/S1097-2765(00)80221-X.
- Montrucchio, G.; Lupia, E.; Battaglia, E.; Passerini, G.; Bussolino, F.; Emanuelli, G.; Camussi, G. Tumor Necrosis Factor Alpha-Induced Angiogenesis Depends on in Situ Platelet-Activating Factor Biosynthesis. J. Exp. Med. 1994, 180(1), 377–382. DOI: https://doi.org/10.1084/jem.180.1.377.
- Östman, A.; Betsholtz, C. Platelet-Derived Growth Factor: Impact on Physiological and Tumor Angiogenesis. Tumor Angiogenes. Basic Mech. Cancer Ther. 2008, 155–169. DOI: https://doi.org/10.1007/978-3-540-33177-3_9.
- Valverde, M. E.; Hernández-Perez, T.; Paredes-López, O. Edible Mushrooms: Improving Human Health and Promoting Quality Life. Int. J. Microbiol. 2013, 2015(Table 1), 1–14. DOI: https://doi.org/10.1155/2015/376387.
- Chatterjee, A.; Acharya, K. Include Mushroom in Daily Diet—A Strategy for Better Hepatic Health. Food Rev. Int. 2016, 32(1), 68–97. DOI: https://doi.org/10.1080/87559129.2015.1057839.
- Acharya, K.; Ghosh, S.; Dutta, A. K. Pharmacognostic Standardization Based on Physicochemical and Molecular Parameters of a Medicinal Mushroom Schizophyllum Commune. Orient. Pharm. Exp. Med. 2016, 16(4), 259–266. DOI: https://doi.org/10.1007/s13596-016-0241-y.
- Adenipekun, C. O.;. Uses of Mushrooms in Bioremediation: A Review. Biotechnol. Mol. Biol. Rev. 2012, 7(3). DOI: https://doi.org/10.5897/BMBR12.006.
- Stephenson, S. L.;. The Kingdom Fungi: The Biology of Mushrooms, Molds, and Lichens, Portland, Oregon, The Timber Press. 2010.
- Velíšek, J.; Cejpek, K. Pigments of Higher Fungi: A Review. Czech J. Food Sci. 2011, 29(2), 87–102. DOI: https://doi.org/10.17221/524/2010-CJFS.
- Mansouri, K.; Mahamed-Khosroushahi, L.; Rasouli, H. Anti-Angiogenic_inflammatory Behavior of Mushroom Ganoderma Lucidum Extract Could Be Effective for Treatment of Corneal Neovascularization: A Hypothesis | Mansouri | (J. J. Rep. Pharm. Sci. 2014, 3(1), 14–18.
- Seon, Y.; Kim, S.; Sa, J.; Jin, C.; Lim, C.; Park, E. Anti-Angiogenic and Inhibitory Activity on Inducible Nitric Oxide Production of the Mushroom Ganoderma Lucidum. J Ethnopharmacol. 2004, 90, 17–20. DOI:https://doi.org/10.1016/j.jep.2003.09.006.
- Cao, Q.-Z.; Lin, Z.-B. Antitumor and Anti-Angiogenic Activity of Ganoderma Lucidum Polysaccharides Peptide. Acta Pharmacol. Sin. 2004, 25(6), 833–838.
- Gao, Y.; Zhou, S.; Jiang, W.; Huang, M. Effects of Ganopoly (A Ganoderma Lucidum Polysaccharide Extract) on the Immune Functions in Advanced-Stage Cancer Patients. Immunol Invest. 2003, 32(3), 201–215. DOI: https://doi.org/10.1081/IMM-120022979.
- Cao, L. Z.; Lin, Z. B. Regulation on Maturation and Function of Dendritic Cells by Ganoderma Lucidum Polysaccharides. Immunol. Lett. 2002, 83(3), 163–169. DOI: https://doi.org/10.1016/S0165-2478(02)00087-1.
- Dias, S.; Boyd, R.; Balkwill, F. IL-12 Regulates VEGF and MMPs in a Murine Breast Cancer Model. Immunol. Lett. 2002, 83, 163–169. DOI: https://doi.org/10.1016/s0165-2478(02)00087-1.
- Angiolillo, A. L.; Sgadari, C.; Taub, D. D.; Liao, F.; Farber, J. M.; Maheshwari, S.; Kleinman, H. K.; Reaman, G. H.; Tosato, G. Human Interferon-Inducible Protein 10 Is a Potent Inhibitor of Angiogenesis in Vivo. J. Exp. Med. 1995, 182, 155–162. DOI: https://doi.org/10.1084/jem.182.1.155.
- Aoita, Y. Y.; Atsuki, K. M.; Ijima, T. I.; Akano, S. N.; Akuda, R. K.; Achida, K. M.; Ikuchi, M. K. New Sterols and Triterpenoids from Four Edible Mushrooms 1). Chem Pharm Bull (Tokyo). 2001, 49(May), 3–8.
- Kimura, Y.; Taniguchi, M.; Baba, K. Antitumor and Antimetastatic Effects on Liver of Triterpenoid Fractions of Ganoderma Lucidum: Mechanism of Action and Isolation of an Active Substance. Anticancer Res. 2002, 22(6A), 3309–3318.
- Yuen, J. W.; Gohel, M. D. Anticancer Effects of Ganoderma Lucidum: A Review of Scientific Evidence. Nutr. Cancer. 2005, 53(1), 11–17. DOI: https://doi.org/10.1207/s15327914nc5301_2.
- Stanley, G.; Harvey, K.; Slivova, V.; Jiang, J.; Sliva, D. Ganoderma Lucidum Suppresses Angiogenesis through the Inhibition of Secretion of VEGF and TGF-?1 from Prostate Cancer Cells. Biochem. Biophys. Res. Commun. 2005, 330(1), 46–52. DOI: https://doi.org/10.1016/j.bbrc.2005.02.116.
- Tamarat, R.; Silvestre, J. S.; Durie, M.; Levy, B. I. Angiotensin II Angiogenic Effect in Vivo Involves Vascular Endothelial Growth Factor- and Inflammation-Related Pathways. Lab. Invest. 2002, 82(6), 747–756. DOI: https://doi.org/10.1097/01.LAB.0000017372.76297.EB.
- Morigiwa, A.; Kitabatake, K.; Fujimoto, Y.; Ikekawa, N. Angiotensin Converting Enzyme-Inhibitory Triterpenes from Ganoderma Lucidum. Chem. Pharm. Bull. (Tokyo) Jul 1986, 34(7), 3025–3028. DOI: https://doi.org/10.1248/cpb.34.3025.
- Sliva, D.; Labarrere, C.; Slivova, V.; Sedlak, M.; Lloyd, F. P.; Ho, N. W. Y. Ganoderma Lucidum Suppresses Motility of Highly Invasive Breast and Prostate Cancer Cells. Biochem. Biophys. Res. Commun. 2002, 298(4), 603–612. Pii S0006-291x(02)02496-8. DOI: https://doi.org/10.1016/S0006-291X(02)02496-8.
- Miura, T.; Yuan, L.; Sun, B.; Fujii, H.; Yoshida, M.; Wakame, K.; Kosuna, K. Isoflavone Aglycon Produced by Culture of Soybean Extracts with Basidiomycetes and Its Anti-Angiogenic Activity. Biosci. Biotechnol. Biochem. 2002, 66(12), 2626–2631. DOI: https://doi.org/10.1271/bbb.66.2626.
- Fotsis, T.; Pepper, M.; Adlercreutz, H. Genistein, a Dietary Ingested Isoflavonoid, Inhibits Cell Proliferation and in Vitro Angiogenesis. J. Nutr. 1995, 125(3 Suppl), 790S–797S. DOI: https://doi.org/10.1093/jn/125.suppl_3.790S.
- Hsu, S.-C.; Ou, -C.-C.; Chuang, T.-C.; Li, J.-W.; Lee, Y.-J.; Wang, V.; Liu, J.-Y.; Chen, C.-S.; Lin, S.-C.; Kao, M.-C. Ganoderma Tsugae Extract Inhibits Expression of Epidermal Growth Factor Receptor and Angiogenesis in Human Epidermoid Carcinoma Cells: In Vitro and in Vivo. Cancer Lett. 2009, 281(1), 108–116. DOI: https://doi.org/10.1016/j.canlet.2009.02.032.
- Hsu, S. C.; Ou, C. C.; Li, J. W.; Chuang, T. C.; Kuo, H. P.; Liu, J. Y.; Chen, C. S.; Lin, S. C.; Su, C. H.; Kao, M. C. Ganoderma Tsugae Extracts Inhibit Colorectal Cancer Cell Growth via G2/M Cell Cycle Arrest. J. Ethnopharmacol. 2008, 120(3), 394–401. DOI: https://doi.org/10.1016/j.jep.2008.09.025.
- Ko, J.-L.; Chen, T.-C. Compositions Comprising Fungal Immunomodulatory Protein and Use Thereof US 8629096 B2. US 8,629,096 B2. United States Patent.Jan. 14, 2014.
- Lin, C. H.; Sheu, G. T.; Lin, Y. W.; Yeh, C. S.; Huang, Y. H.; Lai, Y. C.; Chang, J. G.; Ko, J. L. A New Immunomodulatory Protein from Ganoderma Microsporum Inhibits Epidermal Growth Factor Mediated Migration and Invasion in A549 Lung Cancer Cells. Process Biochem. 2010, 45(9), 1537–1542. DOI: https://doi.org/10.1016/j.procbio.2010.06.006.
- Bok, J. W.; Lermer, L.; Chilton, J.; Klingeman, H. G.; Towers, G. H. N. Antitumor Sterols from the Mycelia of Cordyceps Sinensis. Phytochemistry. 1999, 51(7), 891–898. DOI: https://doi.org/10.1016/S0031-9422(99)00128-4.
- Rhee, Y.; Jeong, S.; Lee, H.; Lee, H.; Koh, W.; Jung, J.; Kim, S.; Kim, S. Inhibition of STAT3 Signaling and Induction of SHP1 Mediate Antiangiogenic and Antitumor Activities of Ergosterol Peroxide in U266 Multiple Myeloma Cells. BMC Cancer. 2012, 12(1), 28. DOI: https://doi.org/10.1186/1471-2407-12-28.
- Rottman, F.; Guarino, A. J. The Inhibition of Phosphoribosyl-Pyrophosphate Amidotransferase Activity by Cordycepin Monophosphate. Biochim. Biophys. Acta - Spec. Sect. Enzymol. Subj. 1964, 89(3), 465–472. DOI: https://doi.org/10.1016/0926-6569(64)90072-0.
- Lu, H.; Li, X.; Zhang, J.; Shi, H.; Zhu, X.; He, X. Effects of Cordycepin on HepG2 and EA.Hy926 Cells: Potential Antiproliferative, Antimetastatic and Anti-Angiogenic Effects on Hepatocellular Carcinoma. Oncol. Lett. 2014, 7(5), 1556–1562. DOI: https://doi.org/10.3892/ol.2014.1965.
- Won, S. Y.; Park, E. H. Anti-Inflammatory and Related Pharmacological Activities of Cultured Mycelia and Fruiting Bodies of Cordyceps Militaris. J. Ethnopharmacol. 2005, 96(3), 555–561. DOI: https://doi.org/10.1016/j.jep.2004.10.009.
- TULI, H. S.; SANDHU, S. S.; SHARMA, A. K.; GANDHI, P. Anti-angiogenic Activity of the Extracted Fermentation Broth of an Entomopathogenic Fungus, Cordyceps Militaris. Int. J. Pharm. Pharm. Sci. 2014, 6(7), 581–583.
- Sun, Y.; Shao, Y.; Zhang, Z.; Wang, L.; Mariga, A. M.; Pang, G.; Geng, C.; Ho, C. T.; Hu, Q.; Zhao, L. Regulation of Human Cytokines by Cordyceps Militaris. J. Food Drug Anal. 2014, 22(4), 463–467. DOI: https://doi.org/10.1016/j.jfda.2014.01.025.
- Ruma, I. M. W.; Putranto, E. W.; Kondo, E.; Watanabe, R.; Saito, K. E. N.; Inoue, Y.; Yamamoto, K. I.; Nakata, S.; Kaihata, M.; Murata, H.;, et al. Extract of Cordyceps Militaris Inhibits Angiogenesis and Suppresses Tumor Growth of Human Malignant Melanoma Cells. Int. J. Oncol. 2014, 45(1), 209–218. DOI: https://doi.org/10.3892/ijo.2014.2397.
- Yoo, H.; Shin, J.; Cho, J.; Son, C.; Lee, Y.; Park, S.; Cho, C. Effects of Cordyceps Militaris Extract on Angiogenesis and Tumor Growth. Acta Pharmacol. Sin. 2004, 25(5), 657–665.
- Liu, R.-M.; Zhang, X.-J.; Liang, G.-Y.; Yang, Y.-F.; Zhong, -J.-J.; Xiao, J.-H. Antitumor and Antimetastatic Activities of Chloroform Extract of Medicinal Mushroom Cordyceps Taii in Mouse Models. BMC Complement. Altern. Med. 2015, 15(1), 216. DOI: https://doi.org/10.1186/s12906-015-0762-9.
- Jin, E.; Han, S.; Son, M.; Kim, S. Cordyceps Bassiana Inhibits Smooth Muscle Cell Proliferation via the ERK1/2 MAPK Signaling Pathway. Cell. Mol. Biol. Lett. 2016, 1–8. DOI: https://doi.org/10.1186/s11658-016-0023-z.
- Kimura, Y.; Kido, T.; Takaku, T.; Sumiyoshi, M.; Baba, K. Isolation of an Anti-Angiogenic Substance from Agaricus Blazei Murill: Its Antitumor and Antimetastatic Actions. Cancer Sci. 2004, 95(9), 758–764. DOI: https://doi.org/10.1111/j.1349-7006.2004.tb03258.x.
- NIU, Y. C.; LIU, J. C.; ZHAO, X. M.; WU, X. X. A Low Molecular Weight Polysaccharide Isolated from Agaricus Blazei Suppresses Tumor Growth and Angiogenesis in Vivo. Oncol. Rep. 2009, 21, 145–152. DOI: https://doi.org/10.3892/or_00000201.
- Takaku, T.; Kimura, Y.; Okuda, H. Isolation of an Antitumor Compound from Agaricus Blazei Murrill and Its Mechanism of Action. J. Nutr. 2001, 131(December 2000), 1409–1413. DOI: https://doi.org/10.1093/jn/131.5.1409.
- Pinto, A. V. F. D. S.; Martins, P. R.; Romagnoli, G. G.; Campanelli, A. P.; Terezan, A. P.; Filho, E. R.; Eira, A. F. D.; Kaneno, R. Polysaccharide Fraction of Agaricus Brasiliensis Avoids Tumor-Induced IL-10 Production and Changes the Microenvironment of Subcutaneous Ehrlich Adenocarcinoma. Cell. Immunol. 2009, 256(1–2), 27–38. DOI: https://doi.org/10.1016/j.cellimm.2009.01.002.
- Chiu, K.; Chen, T.; Wen, C.; Lai, J.; Cheng, C.; Liu, H.; Hsu, S.; Tzeng, Y. Antcin-H Isolated from Antrodia Cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP- ?/c-fos-mmp-7 Pathways. Evid.-Based Complementary Altern. Med. 2017, 2017.
- Yang, C. M.; Zhou, Y. J.; Wang, R. J.; Hu, M. L. Anti-Angiogenic Effects and Mechanisms of Polysaccharides from Antrodia Cinnamomea with Different Molecular Weights. J. Ethnopharmacol. 2009, 123(3), 407–412. DOI: https://doi.org/10.1016/j.jep.2009.03.034.
- Cheng, J. J.; Huang, N. K.; Chang, T. T.; Ling Wang, D.; Lu, M. K. Study for Anti-Angiogenic Activities of Polysaccharides Isolated from Antrodia Cinnamomea in Endothelial Cells. Life Sci. 2005, 76(26), 3029–3042. DOI: https://doi.org/10.1016/j.lfs.2004.11.023.
- Liu, Y.; Ding, Y.; Ye, M.; Zhu, T.; Tian, D.; Ding, K. A Novel Heterogalactan from Antrodia Camphorata and Anti-Angiogenic Activity of Its Sulfated Derivative. Polymers (Basel). 2017, 9(6), 228. DOI: https://doi.org/10.3390/polym9060228.
- Shih, C. C.; Lu, M. K.; Cheng, J. J.; Danny, L. W. Antiangiogenic Activities of Polysaccharides Isolated from Medicinal Fungi. FEMS Microbiol. Lett. 2005, 249(2), 247–254. DOI: https://doi.org/10.1016/j.femsle.2005.06.033.
- Song, Y. S.; Kim, S. H.; Sa, J. H.; Jin, C.; Lim, C. J.; Park, E. H. Anti-Angiogenic, Antioxidant and Xanthine Oxidase Inhibition Activities of the Mushroom Phellinus Linteus. J. Ethnopharmacol. 2003, 88(1), 113–116. DOI: https://doi.org/10.1016/S0378-8741(03)00178-8.
- Sil, Y.; Hee, Y.; Kyung, E.; Hwan, D.; Sung, S.; Lee, J.; Kim, J. Anti-Angiogenic Activity of Methanol Extract of Phellinus Linteus and Its Fractions. J. Ethnopharmacol. 2010, 131(1), 56–62. DOI: https://doi.org/10.1016/j.jep.2010.05.064.
- Song, K.-S.; Li, G.; Kim, J.-S.; Jing, K.; Kim, T.-D.; Kim, J.-P.; Seo, S.-B.; Yoo, J.-K.; Park, H.-D.; Hwang, B.-D.;, et al. Protein-Bound Polysaccharide from Phellinus Linteus Inhibits Tumor Growth, Invasion, and Angiogenesis and Alters Wnt/b-Catenin in SW480 Human Colon Cancer Cells. BMC Cancer 2011, 11, 307. DOI: https://doi.org/10.1186/1471-2407-11-307.
- Sliva, D.; Jedinak, A.; Kawasaki, J.; Harvey, K.; Slivova, V. Phellinus Linteus Suppresses Growth, Angiogenesis and Invasive Behaviour of Breast Cancer Cells through the Inhibition of AKT Signalling. Br. J. Cancer. 2008, 98(8), 1348–1356. DOI: https://doi.org/10.1038/sj.bjc.6604319.
- Kim, S. H.; Song, Y. S.; Kim, S. K.; Kim, B. C.; Lim, C. J.; Park, E. H. Anti-Inflammatory and Related Pharmacological Activities of the n-BuOH Subfraction of Mushroom Phellinus Linteus. J. Ethnopharmacol. 2004, 93(1), 141–146. DOI: https://doi.org/10.1016/j.jep.2004.03.048.
- Gunde-Cimerman, N.; Cimerman, A. Pleurotus Fruiting Bodies Contain the Inhibitor of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Lovastatin. Exp. Mycol. 1995, 19(1), 1–6. DOI: https://doi.org/10.1006/emyc.1995.1001.
- Lakshmanan, D.; Radha, K. V. Production of Lovastatin from Pleurotus Ostreatus and Comparison with Commercial Tablets. Int. J. Pharm. Pharm. Sci.2012, 2(3), 53–56.
- Zhao, T. T.; Trinh, D.; Addison, C. L.; Dimitroulakos, J. Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors. PLoS One. 2010, 5(9). DOI: https://doi.org/10.1371/journal.pone.0012563.
- Deepalakshmi, K.; Mirunalini, S. On Oxidant/Antioxidant Status in 7, 12 ‑ Dimethylbenz (A) Anthracene Induced Mammary Carcinoma in Experimental Rats ‑ A Dose ‑ Response Study. J. Cancer Res. Ther. 2016, 12(1). DOI: https://doi.org/10.4103/0973-1482.148691.
- Li, S.; Dai, S.; Shah, N. P. Sulfonation and Antioxidative Evaluation of Polysaccharides from Pleurotus Mushroom and Streptococcus Thermophilus Bacteria : A Review. Comprehensive Reviews in Food Science and Food Safety. 2017, 16, 282–294. DOI:https://doi.org/10.1111/1541-4337.12252.
- Sarangi, I.; Ghosh, D.; Bhutia, S. K.; Mallick, S. K.; Maiti, T. K. Anti-Tumor and Immunomodulating Effects of Pleurotus Ostreatus Mycelia-Derived Proteoglycans. International Immunopharmacology. 2006, 6, 1287–1297. DOI: https://doi.org/10.1016/j.intimp.2006.04.002.
- Xu, W.; Huang, J. J.; Chi, P.; Cheung, K. Extract of Pleurotus Pulmonarius Suppresses Liver Cancer Development and Progression through Inhibition of VEGF-Induced PI3K/AKT Signaling Pathway. PLos One. 2012, 7(3). DOI: https://doi.org/10.1371/journal.pone.0034406.
- Khatua, S.; Acharya, K. Mushroom as the Potential Source of New Generation of Antioxidant : A Review. Res. J. Pharm. Technol. No. November 2013. 6(5):496–505.
- Liu, X.; Zhou, B.; Lin, R.; Jia, L.; Deng, P.; Fan, K.; Wang, G.; Wang, L.; Zhang, J. Extraction and Antioxidant Activities of Intracellular Polysaccharide from Pleurotus Sp. Mycelium. Int. J. Biol. Macromol. 2010, 47, 116–119. DOI: https://doi.org/10.1016/j.ijbiomac.2010.05.012.
- Shenbhagaraman, R.; Jagadish, L. K.; Premalatha, K. International Journal of Biological Macromolecules Optimization of Extracellular Glucan Production from Pleurotus Eryngii and Its Impact on Angiogenesis. Int. J. Biol. Macromol. 2012, 50(4), 957–964. DOI: https://doi.org/10.1016/j.ijbiomac.2012.02.008.
- Hu, Q.; Du, H.; Ma, G.; Pei, F.; Ma, N.; Yuan, B. Function Protein from Pleurotus Eryngii. Food Funct. 2018, 3764–3775. DOI:https://doi.org/10.1039/c8fo00604k.
- Lin, S.; Lai, T.; Chen, L.; Kwok, H.; Lau, C. B.; Cheung, P. C. K. Antioxidant and Antiangiogenic Properties of Phenolic Extract from Pleurotus Tuber-Regium, J Agric Food Chem. 2014.
- Wang, X.; Zhang, N.; Huo, Q.; Yang, Q. Anti-Angiogenic and Antitumor Activities of Huaier Aqueous Extract. Oncol. Rep. 2012, 28(4), 1167–1175. DOI: https://doi.org/10.3892/or.2012.1961.
- Zou, Y.; Xiong, H. H.; Xiong, H. H.; Lu, T.; Zhu, F.; Luo, Z.; Yuan, X.; Wang, Y. A Polysaccharide from Mushroom Huaier Retards Human Hepatocellular Carcinoma Growth, Angiogenesis, and Metastasis in Nude Mice. Tumor Biol. 2014. DOI: https://doi.org/10.1007/s13277-014-2923-8.
- Zhang, W.; Men, X.; Lei, P. Review on Anti-Tumor Effect of Triterpene Acid Compounds. J. Cancer Res. Ther. 2014, 10 Suppl 1(5), 14–19. DOI: https://doi.org/10.4103/0973-1482.139746.
- Lee, J.-S.; Park, B. C.; Ko, Y. J.; Choi, M. K.; Choi, H. G.; Yong, C. S.; Lee, J.-S.; Kim, J.-A. Grifola Frondosa (Maitake Mushroom) Water Extract Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis through Inhibition of Reactive Oxygen Species and Extracellular Signal-Regulated Kinase Phosphorylation. J. Med. Food. 2008, 11(4), 643–651. DOI: https://doi.org/10.1089/jmf.2007.0629.
- Cheng, J. J.; Lin, C. Y.; Lur, H. S.; Chen, H. P.; Lu, M. K. Properties and Biological Functions of Polysaccharides and Ethanolic Extracts Isolated from Medicinal Fungus, Fomitopsis Pinicola. Process Biochem. 2008, 43(8), 829–834. DOI: https://doi.org/10.1016/j.procbio.2008.03.005.
- Song, J.; Manir, M. M.; Moon, S. S. Cytotoxic Grifolin Derivatives Isolated from the Wild Mushroom Boletus Pseudocalopus (Basidiomycetes). Chem. Biodivers. 2009, 6(9), 1435–1442. DOI: https://doi.org/10.1002/cbdv.200800217.
- Luo, X.; Yang, L.; Xiao, L.; Xia, X.; Dong, X.; Liu, Y.; Li, N.; Chen, L.; Li, H.; Li, W.;; et al. Grifolin Directly Targets ERK1/2 to Epigenetically Suppress Cancer Cell Metastasis. Oncotarget. 6(40). DOI: https://doi.org/10.18632/oncotarget.5678.
- Kaneko, A.; Tsukada, M.; Fukai, M.; Suzuki, T.; Nishio, K.; Miki, K.; Kinoshita, K.; Takahashi, K.; Koyama, K. KDR Kinase Inhibitor Isolated from the Mushroom Boletopsis Leucomelas. J. Nat. Prod. 2010, 73(5), 1002–1004. DOI: https://doi.org/10.1021/np100113e.
- DeLisser, H. M.; Christofidou-Solomidou, M.; Strieter, R. M.; Burdick, M. D.; Robinson, C. S.; Wexler, R. S.; Kerr, J. S.; Garlanda, C.; Merwin, J. R.; Madri, J. A.;; et al. Involvement of Endothelial PECAM-1/CD31 in Angiogenesis. Am. J. Pathol. 1997, 151(3), 671–677.
- Arata, S.; Watanabe, J.; Maeda, M.; Yamamoto, M.; Matsuhashi, H.; Mochizuki, M.; Kagami, N.; Honda, K.; Inagaki, M. Continuous Intake of the Chaga Mushroom (Inonotus Obliquus) Aqueous Extract Suppresses Cancer Progression and Maintains Body Temperature in Mice. Heliyon. 2016, 2(5). DOI: https://doi.org/10.1016/j.heliyon.2016.e00111.
- Sagar, S. M.; Yance, D.; Wong, R. K. Natural Health Products that Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer - Part 2. Curr. Oncol. 2006, 13(3), 14–26.
- Yance, D. R.; Sagar, S. M. Targeting Angiogenesis with Integrative Cancer Therapies. Integr. Cancer Ther. 2006, 5(1), 9–29. DOI: https://doi.org/10.1177/1534735405285562.
- Cheng, S.; Eliaz, I.; Lin, J.; Sliva, D. Triterpenes from Poria Cocos Suppress Growth and Invasiveness of Pancreatic Cancer Cells through the Downregulation of MMP-7. Int. J. Oncol. 2013, 42(6), 1869–1874. DOI: https://doi.org/10.3892/ijo.2013.1902.
- Chang, H. C.; Yang, H. L.; Pan, J. H.; Korivi, M.; Pan, J. Y.; Hsieh, M. C.; Chao, P. M.; Huang, P. J.; Tsai, C. T.; Hseu, Y. C. Hericium Erinaceus Inhibits TNF- α -induced Angiogenesis and ROS Generation through Suppression of MMP-9/NF-ΚB Signaling and Activation of Nrf2-Mediated Antioxidant Genes in Human EA.Hy926 Endothelial Cells. Oxid. Med. Cell. Longev. 2016, 2016. DOI: https://doi.org/10.1155/2016/8257238.
- Chang, Y. C.; Hsiao, Y. M.; Hung, S. C.; Chen, Y. W.; Ou, C. C.; Chang, W. T.; Lue, K. H.; Ko, J. L. Alleviation of Dermatophagoides Microceras-Induced Allergy by an Immunomodulatory Protein, FIP-Fve, from Flammulina Velutipes in Mice. Biosci. Biotechnol. Biochem. 2015, 79(1), 88–96. DOI: https://doi.org/10.1080/09168451.2014.956682.
- HSU, H.-C.; HSU, C.-I.; LIN, R.-H.; KAO, C.-L.; LIN, J.-Y. Fip-Vvo, a New Fungal Immunomodulatory Protein Isolated from Volvariella Volvacea. Biol. Cultiv. Edible Mushrooms. 1997, 323, 557–565. DOI: https://doi.org/10.1016/B978-0-12-168050-3.50033-5.
- Ding, Y.; Seow, S. V.; Huang, C. H.; Liew, L. M.; Lim, Y. C.; Kuo, I. C.; Chua, K. Y. Coadministration of the Fungal Immunomodulatory Protein FIP-Fve and a Tumour-Associated Antigen Enhanced Antitumour Immunity. Immunology. 2009, 128(1 PART 2), 881–894. DOI: https://doi.org/10.1111/j.1365-2567.2009.03099.x.
- Vyas, D.; Laput, G.; Vyas, A. K. Chemotherapy-Enhanced Inflammation May Lead to the Failure of Therapy and Metastasis. Oncol. Targets. Ther. 2014, 7, 1015–1023. DOI: https://doi.org/10.2147/OTT.S60114.
- Gonzalez-Angulo, A.; Morales-Vasquez, F.; Hortobagyi, G. Overview of Resistance to Systemic Therapy in Patients with Breast Cancer. Adv. Exp. Med. Biol. 2007, 608, 1–22.
- Haq, R.; Zanke, B. Inhibition of Apoptotic Signaling Pathways in Cancer Cells as a Mechanism of Chemotherapy Resistance. Cancer and Metastasis Reviews. 1998, 17,233–239. DOI: https://doi.org/10.1023/A:1006075007857.
- Stamets, P.; Zwickey, H. Medicinal Mushrooms: Ancient Remedies Meet Modern Science. Integr. Med. A Clin. J. 2014, 13(1), 46–47.
- Imai, K.; Takaoka, A. Comparing Antibody and Small-Molecule Therapies for Cancer. Nat. Rev. Cancer. 2006, 6(9), 714–727. DOI: https://doi.org/10.1038/nrc1913.
- Esteva, F. J.;. Monoclonal Antibodies, Small Molecules, and Vaccines in the Treatment of Breast Cancer. Oncologist. 2004, 9(suppl_3), 4–9. DOI: https://doi.org/10.1634/theoncologist.9-suppl_3-4.
- Ranpura, V.; Hapani, S.; Wu, S. Treatment-Related Mortality with Bevacizumab in Cancer Patients. Jama. 2011, 305(5), 487. DOI: https://doi.org/10.1001/jama.2011.51.
- Khatua, S.; Acharya, K. Alkaline Extractive Crude Polysaccharide from Russula Senecis Possesses Antioxidant Potential and Stimulates Innate Immunity Response. J. Pharm. Pharmacol. 2017, 1–12. DOI: https://doi.org/10.1111/jphp.12813.
- Jana, P.; De, S. K.; Sinha, A. K.; Guha, S.; Khan, G. A.; Maiti, S. Estriol Inhibits Dermcidin Isoform-2 Induced Inflammatory Cytokine Expression via Nitric Oxide Synthesis in Human Neutrophil. 2018, 18 (10), 672–678. DOI:https://doi.org/10.2174/1566524019666190208095754.
- Jana, P.; Maiti, S.; Kahn, N. N.; Sinha, A. K. Estriol-Induced Fibrinolysis Due to the Activation of Plasminogen to Plasmin by Nitric Oxide Synthesis in Platelets. Blood Coagul. Fibrinolysis. 2015, 26(3). DOI: https://doi.org/10.1097/MBC.0000000000000085.
- Sun, H.; Partick, Y. K.; Yue, S.-R. W.; Huo, L.; Zhao, Y.; Xie, S.; Kringelum, J. V.; Lund, O.; Taboureau, O.; Zhou, J.; et al. Synthesis and Biological Evaluations of Cytotoxic and Antiangiogenic Triterpenoids-Jacaranone Conjugates. Med. Chem. (Los. Angeles) 2016, 8, 775–785. DOI: https://doi.org/10.2174/1573406412666160502153930.
- Wu, F. L.; Shi, L.; Yao, J.; Ren, A.; Zhou, C.; Mu, D.; Zhao, M. W. The Cloning, Characterization, and Functional Analysis of a Gene Encoding an Isopentenyl Diphosphate Isomerase Involved in Triterpene Biosynthesis in the Lingzhi or Reishi Medicinal Mushroom Ganoderma Lucidum (Higher Basidiomycetes). Int. J. Med. Mushrooms. 2013, 15(3), 223–232. DOI: https://doi.org/10.1615/IntJMedMushr.v15.i3.10.
- Xu, Y. N.; Zhong, J. J. Impacts of Calcium Signal Transduction on the Fermentation Production of Antitumor Ganoderic Acids by Medicinal Mushroom Ganoderma Lucidum. Biotechnol. Adv. 2012, 30(6), 1301–1308. DOI: https://doi.org/10.1016/j.biotechadv.2011.10.001.
- Lin, Y.; Zhang, L.; Chen, L.; Jin, Y.; Zeng, F.; Jin, J.; Wan, B.; Cheung, P. C. K. Molecular Mass and Antitumor Activities of Sulfated Derivatives of α-Glucan from Poria Cocos Mycelia. Int. J. Biol. Macromol. 2004, 34(5), 231–236. DOI: https://doi.org/10.1016/j.ijbiomac.2004.08.001.
- Cheng, J. J.; Chang, C. C.; Chao, C. H.; Lu, M. K. Characterization of Fungal Sulfated Polysaccharides and Their Synergistic Anticancer Effects with Doxorubicin. Carbohydr. Polym. 2012, 90(1), 134–139. DOI: https://doi.org/10.1016/j.carbpol.2012.05.005.
- Martin, D.; Maguire, M. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. New Engl. 2011, 364(20), 1–12. DOI: https://doi.org/10.1056/NEJMoa1102673.Ranibizumab.
- Harper, S. J.; Bates, D. O. UKPMC Funders Group VEGF-A Splicing. Microvasc. Res. 2009, 8(11), 880–887. DOI: https://doi.org/10.1038/nrc2505.VEGF-A.